Indeed, transgenic mice systemically expressing the bacterial cagA gene exhibit gastric epithelial hyperplasia, gastrointestinal carcinomas, and B cell lymphomas, indicating that CagA acts as an oncoprotein in mammals13. Here, S100A8 is linked to digestive system carcinoma.